These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9194954)

  • 1. Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets.
    Hampel H; Kötter HU; Möller HJ
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):78-87. PubMed ID: 9194954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation.
    Hampel H; Müller-Spahn F; Berger C; Haberl A; Ackenheil M; Hock C
    Dementia; 1995; 6(6):348-54. PubMed ID: 8563789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis.
    Hampel H; Kötter HU; Padberg F; Körschenhausen DA; Möller HJ
    Alzheimer Dis Assoc Disord; 1999 Jan; 13(1):9-19. PubMed ID: 10192637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.
    Chalbot S; Zetterberg H; Blennow K; Fladby T; Andreasen N; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2011; 25(3):505-15. PubMed ID: 21471645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.
    Frölich L; Kornhuber J; Ihl R; Fritze J; Maurer K; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):363-6. PubMed ID: 1831668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.
    Alafuzoff I; Adolfsson R; Bucht G; Winblad B
    J Neurol Sci; 1983; 60(3):465-72. PubMed ID: 6631444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease.
    Haussermann P; Kuhn W; Przuntek H; Muller T
    Neurosci Lett; 2001 Mar; 300(3):182-4. PubMed ID: 11226641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.
    Elovaara I; Palo J; Erkinjuntti T; Sulkava R
    Eur Neurol; 1987; 26(4):229-34. PubMed ID: 3595662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    Muszyński P; Kulczyńska-Przybik A; Borawska R; Litman-Zawadzka A; Słowik A; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Mroczko B
    J Alzheimers Dis; 2017; 59(3):903-912. PubMed ID: 28697565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment.
    Zetterberg H; Jakobsson J; Redsäter M; Andreasson U; Pålsson E; Ekman CJ; Sellgren C; Johansson AG; Blennow K; Landén M
    Psychiatry Res; 2014 Jul; 217(3):143-6. PubMed ID: 24745469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis.
    Elovaara I; Icén A; Palo J; Erkinjuntti T
    J Neurol Sci; 1985 Aug; 70(1):73-80. PubMed ID: 4045502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias.
    Mecocci P; Parnetti L; Reboldi GP; Santucci C; Gaiti A; Ferri C; Gernini I; Romagnoli M; Cadini D; Senin U
    Acta Neurol Scand; 1991 Sep; 84(3):210-3. PubMed ID: 1950463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF and serum concentrations of albumin and IgG in Alzheimer's disease.
    Kay AD; May C; Papadopoulos NM; Costello R; Atack JR; Luxenberg JS; Cutler NR; Rapoport SI
    Neurobiol Aging; 1987; 8(1):21-5. PubMed ID: 3561662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.
    Bowman GL; Kaye JA; Moore M; Waichunas D; Carlson NE; Quinn JF
    Neurology; 2007 May; 68(21):1809-14. PubMed ID: 17515542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid.
    Leonardi A; Gandolfo C; Caponnetto C; Arata L; Vecchia R
    J Neurol Sci; 1985 Feb; 67(2):253-61. PubMed ID: 3981221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
    Tumani H; Huss A; Bachhuber F
    Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients.
    Livrea P; Trojano M; Simone IL; Zimatore GB; Pisicchio L; Logroscino G; Cibelli G
    J Neurol Sci; 1984 Jun; 64(3):245-58. PubMed ID: 6206205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid and Blood Biomarkers of Neuroinflammation and Blood-Brain Barrier in Psychotic Disorders and Individually Matched Healthy Controls.
    Jeppesen R; Orlovska-Waast S; Sørensen NV; Christensen RHB; Benros ME
    Schizophr Bull; 2022 Nov; 48(6):1206-1216. PubMed ID: 35939296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.
    Chalbot S; Zetterberg H; Blennow K; Fladby T; Grundke-Iqbal I; Iqbal K
    Neurosci Lett; 2010 Jul; 478(3):179-83. PubMed ID: 20470866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.